会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • A SOLID PHARMACEUTICAL COMPOSITION WITH ATORVASTATIN AND TELMISARTAN AS THE ACTIVE SUBSTANCES
    • 以ATORVASTATIN和TELMISARTAN为活性物质的固体药物组合物
    • WO2010057449A3
    • 2011-03-17
    • PCT/CZ2009000138
    • 2009-11-16
    • ZENTIVA K SPROKOPOVA ALENALINEK JANGRYCZOVA EVA
    • PROKOPOVA ALENALINEK JANGRYCZOVA EVA
    • A61K9/16A61K9/20A61K31/00
    • A61K31/40A61K9/2009A61K9/2018A61K9/2086A61K9/5084A61K31/4184A61K45/06A61K2300/00
    • A solid pharmaceutical composition with the active substances telmisartan and atorvastatin, characterized by in that both the substances are in the form of alkali or alkaline earth salts and the composition further contains an organic or inorganic base selected from the substances meglumine, sodium or potassium hydroxide, calcium or magnesium or sodium or potassium hydroxide, oxide or carbonate, and further polyvinyl pyrrolidone and a filler selected either from: a) a mono- or oligosaccharide soluble in water, or an alcoholic sugar, the size of 95% by weight of all particles of the filler, which may be present in the composition either individually or combined in larger granules, 99% by weight of which are smaller than 1.0 mm, being in the range of 0.025 to 0.355 mm; b) or a polysaccharide insoluble in water, 95% by weight of all particles of the filler, which may be present in the composition either individually or combined in large granules, 75% by weight of which are smaller than 0.50 mm, being smaller than 0.25 mm.
    • 一种具有活性物质替米沙坦和阿托伐他汀的固体药物组合物,其特征在于两种物质均为碱金属盐或碱土金属盐,组合物还含有选自葡甲胺,氢氧化钠或氢氧化钾的有机或无机碱, 钙或镁或氢氧化钠或氢氧化钾或氢氧化钾或碳酸钾,以及另外的聚乙烯吡咯烷酮和填料,其选自:a)可溶于水的单糖或寡糖或醇糖,所述颗粒的大小为所有颗粒的95重量% 的填料,其可以单独存在或组合成较大颗粒,其中99重量%小于1.0mm,在0.025至0.355mm的范围内; b)或不溶于水的多糖,95重量%的所有填料颗粒,其可以单独存在或组合在大颗粒中,75重量%小于0.50毫米,小于0.50毫米 0.25毫米。
    • 4. 发明申请
    • A SOLID PHARMACEUTICAL COMPOSITION WITH ATORVASTATIN AND TELMISARTAN AS THE ACTIVE SUBSTANCES
    • 以ATORVASTATIN和TELMISARTAN为活性物质的固体药物组合物
    • WO2010057449A2
    • 2010-05-27
    • PCT/CZ2009/000138
    • 2009-11-16
    • ZENTIVA, K.S.PROKOPOVA AlenaLINEK JanGRYCZOVA Eva
    • PROKOPOVA AlenaGRYCZOVA Eva
    • A61K9/16A61K9/20A61K31/00
    • A61K31/40A61K9/2009A61K9/2018A61K9/2086A61K9/5084A61K31/4184A61K45/06A61K2300/00
    • A solid pharmaceutical composition with the active substances telmisartan and atorvastatin, characterized by in that both the substances are in the form of alkali or alkaline earth salts and the composition further contains an organic or inorganic base selected from the substances meglumine, sodium or potassium hydroxide, calcium or magnesium or sodium or potassium hydroxide, oxide or carbonate, and further polyvinyl pyrrolidone and a filler selected either from: a) a mono- or oligosaccharide soluble in water, or an alcoholic sugar, the size of 95% by weight of all particles of the filler, which may be present in the composition either individually or combined in larger granules, 99% by weight of which are smaller than 1.0 mm, being in the range of 0.025 to 0.355 mm; b) or a polysaccharide insoluble in water, 95% by weight of all particles of the filler, which may be present in the composition either individually or combined in large granules, 75% by weight of which are smaller than 0.50 mm, being smaller than 0.25 mm.
    • 一种具有活性物质替米沙坦和阿托伐他汀的固体药物组合物,其特征在于两种物质均为碱金属盐或碱土金属盐,组合物还含有选自葡甲胺,氢氧化钠或氢氧化钾的有机或无机碱, 钙或镁或氢氧化钠或氢氧化钾或氢氧化钾或碳酸钾,以及另外的聚乙烯吡咯烷酮和填料,其选自:a)可溶于水的单糖或寡糖或醇糖,所述颗粒的大小为所有颗粒的95重量% 的填料,其可以单独存在或组合成较大颗粒,其中99重量%小于1.0mm,在0.025至0.355mm的范围内; b)或不溶于水的多糖,95重量%的所有填料颗粒,其可以单独存在或组合在大颗粒中,75重量%小于0.50毫米,小于0.50毫米 0.25毫米。